Hasil Pencarian - Thomas J. Polascik
- Menampilkan 1 - 15 hasil dari 15
-
1
Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases oleh Thomas J Polascik
Diterbitkan 2008-12-01
Artikel -
2
Zoledronic acid in the management of metastatic bone disease oleh Thomas J Polascik, Vladimir Mouraviev
Diterbitkan 2008-03-01
Artikel -
3
-
4
-
5
Engaging the primary care community to encourage appropriate prostate cancer screening oleh Malhar P. Patel, Ariel Schulman, Kevin P. Shah, John B. Anderson, Thomas J. Polascik
Diterbitkan 2018-01-01
Artikel -
6
-
7
Does the type of cryoprobe affect oncological and functional outcomes in men with clinically localized prostate cancer treated with primary whole gland prostate cryoablation? oleh Tarek Taha, Wei Phin Tan, Ahmed Elshafei, Alireza Aminsharifi, Robert Given, Michael L. Cher, Thomas J. Polascik
Diterbitkan 2021-06-01
Artikel -
8
Anterior gland focal cryoablation: proof-of-concept primary prostate cancer treatment in select men with localized anterior cancers detected by multi-parametric magnetic resonance... oleh Christina Sze, Efrat Tsivian, Kae Jack Tay, Ariel A. Schulman, Leah G. Davis, Rajan T. Gupta, Thomas J. Polascik
Diterbitkan 2019-12-01
Artikel -
9
A Detailed Clinical Case of Localized Prostate Tumors Treated with Nanoparticle-Assisted Sub-Ablative Laser Ablation oleh Yara Kadria-Vili, Jon A. Schwartz, Thomas J. Polascik, Glenn P. Goodrich, David Jorden, Diane Pinder, Naomi J. Halas, Ardeshir R. Rastinehad
Diterbitkan 2024-07-01
Artikel -
10
Surveillance one year post focal cryotherapy for clinically significant prostate cancer using mpMRI and PIRADS v2.1: An initial experience from a prospective phase II mandatory bio... oleh Jyothirmayi Velaga, Kae Jack Tay, Guanqi Hang, Yu Guang Tan, John SP Yuen, Melvin Chua, Rajan T. Gupta, Thomas J. Polascik, Nye Thane Ngo, Yan Mee Law
Diterbitkan 2023-12-01
Artikel -
11
Prostatic alpha-linolenic acid (ALA) is positively associated with aggressive prostate cancer: a relationship which may depend on genetic variation in ALA metabolism. oleh Maria Azrad, Kui Zhang, Robin T Vollmer, John Madden, Thomas J Polascik, Denise C Snyder, Mack T Ruffin, Judd W Moul, Dean Brenner, Robert W Hardy, Wendy Demark-Wahnefried
Diterbitkan 2012-01-01
Artikel -
12
Corrigendum to “Surveillance one year post focal cryotherapy for clinically significant prostate cancer using mpMRI and PIRADS v2.1: An initial experience from a prospective phase... oleh Jyothirmayi Velaga, Kae Jack Tay, Guanqi Hang, Yu Guang Tan, John S.P. Yuen, Melvin L.K. Chua, Rajan T. Gupta, Thomas J. Polascik, Nye Thane Ngo, Yan Mee Law
Diterbitkan 2024-06-01
Artikel -
13
Red Blood Cell Distribution Width Is Associated with All-cause Mortality but Not Adverse Cancer-specific Outcomes in Men with Clinically Localized Prostate Cancer Treated with Radi... oleh Hazem Orabi, Lauren Howard, Christopher L. Amling, William J. Aronson, Matthew R. Cooperberg, Christopher J. Kane, Martha K. Terris, Zachary Klaassen, Jessica L. Janes, Stephen J. Freedland, Thomas J. Polascik
Diterbitkan 2022-03-01
Artikel -
14
Urinary fatty acid biomarkers for prostate cancer detection. oleh Elizabeth Noriega Landa, George E Quaye, Xiaogang Su, Sabur Badmos, Kiana L Holbrook, Thomas J Polascik, Eric S Adams, Sriram Deivasigamani, Qin Gao, Michael H Annabi, Ahsan Habib, Wen-Yee Lee
Diterbitkan 2024-01-01
Artikel -
15
Initial Longitudinal Outcomes of Risk-Stratified Men in Their Forties Screened for Prostate Cancer Following Implementation of a Baseline Prostate-Specific Antigen oleh Zoe D. Michael, Srinath Kotamarti, Rohith Arcot, Kostantinos Morris, Anand Shah, John Anderson, Andrew J. Armstrong, Rajan T. Gupta, Steven Patierno, Nadine J. Barrett, Daniel J. George, Glenn M. Preminger, Judd W. Moul, Kevin C. Oeffinger, Kevin Shah, Thomas J. Polascik
Diterbitkan 2023-07-01Artikel